Skip to content

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02913092
Enrollment
81
Registered
2016-09-23
Start date
2017-05-17
Completion date
2022-05-23
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control

Detailed description

This study will assess the feasibility of using electronic sensors for asthma inhalers in a population of urban minority adults and children with moderate-severe asthma in the Bronx. Investigators will also assess differences in asthma outcomes (specifically asthma control as a primary outcome measure) and treatment adherence in a group of participants with moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach worker monitoring/feedback compared to a group of participants who use inhalers with electronic sensors but without real-time monitoring/feedback.

Interventions

BEHAVIORALElectronic sensor and OW education

MDI sensor-generated alerts will be relayed via app platform on participant's phone and responded to (e.g. outreach worker contacts the patient for a missed dose) in real-time to the intervention group. Outreach worker will also assess intervention group participants' need for further asthma education and provide education over the phone

Sponsors

Stony Wold-Herbert Fund, Inc.
CollaboratorOTHER
Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\>18 years) and children (5-11 years old) with a clinical history (i.e. physician-diagnosed) of asthma * Moderate to severe asthmatics with ≥1 asthma-related ED visits or hospitalizations in the past year * Use of daily controller inhaler medications * Adult non-smokers, or lifetime use \<5 pack years with no smoking in last 1 yr * Smartphone required * English or Spanish speaking

Exclusion criteria

* No smartphone * Use of oral corticosteroids in prior 4 weeks * Pregnancy * Psychiatric conditions

Design outcomes

Primary

MeasureTime frameDescription
Asthma Control Testchange from baseline to 6 monthsvalidated asthma control measure

Secondary

MeasureTime frameDescription
Medication adherencechange from baseline to 6 monthsmeasured by electronic sensor
Health care utilizationchange from baseline to 6 monthsED visits and hospitalizations will be assessed via electronic health records

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026